Live Breaking News & Updates on Reduce Tumor Burden

Stay updated with breaking news from Reduce tumor burden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting

16.05.2022 - Single dose of TRACER AAV vector encoding anti-HER2 antibody reduced CNS tumor burden and extended survival across multiple mouse models of breast cancer brain metastasis Novel AAV5-derived capsid improved transduction in multiple CNS regions and . Seite 1 ....

United States , United Kingdom , Todd Carter , Voyager Therapeutics Inc , American Society Of Gene , Research At Voyager , American Society , Cell Therapy , Reduce Tumor Burden , Breast Cancer , Senior Vice President ,